Lactosylated PLGA nanoparticles containing ϵ-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins

Int J Pharm. 2015 Jan 30;478(2):633-43. doi: 10.1016/j.ijpharm.2014.12.017. Epub 2014 Dec 12.

Abstract

The acidic internal pH environment, initial burst release and lack of targeting property are main limitations of poly(lactide-co-glycolide) (PLGA) nanoparticles for carrying proteins. In this study, ϵ-polylysine (ϵ-PL) was used as an anti-acidic agent and a protein protectant to prepare PLGA nanoparticles for the protein delivery. To obtain the liver-targeting capability, lactosylated PLGA (Lac-PLGA) was synthesized by conjugation of lactose acid to PLGA at both ends, and then used to prepare nanoparticles containing ϵ-PL by the nanoprecipitation method. Bovine serumal bumin (BSA), a negatively charged protein, was efficiently loaded into Lac-PLGA/ϵ-PL nanoparticles and exhibited significant decreased burst release in vitro, sustained release in the blood and increased liver distribution in mice after intravenous injections. The enhanced stability of BSA was due to its electrical interaction with ϵ-PL and the neutralized internal environment of nanoparticles. In conclusion, Lac-PLGA/ϵ-PL nanoparticle system can be used as a promising carrier for the negatively charged proteins.

Keywords: Lactosylated PLGA; Nanoparticle; Protein; Sustained release; ϵ-Polylysine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Survival / drug effects
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / chemistry
  • Drug Delivery Systems*
  • Drug Liberation
  • Female
  • Hep G2 Cells
  • Humans
  • Lactic Acid* / chemistry
  • Lactose* / chemistry
  • Lethal Dose 50
  • Liver / metabolism
  • Male
  • Mice
  • Nanoparticles* / administration & dosage
  • Nanoparticles* / chemistry
  • Nanoparticles* / toxicity
  • Polyglycolic Acid* / chemistry
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polylysine* / chemistry
  • Serum Albumin, Bovine / administration & dosage*
  • Serum Albumin, Bovine / chemistry
  • Serum Albumin, Bovine / pharmacokinetics
  • Toxicity Tests, Acute

Substances

  • Delayed-Action Preparations
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polylysine
  • Polyglycolic Acid
  • Serum Albumin, Bovine
  • Lactic Acid
  • Lactose